Geltor Closes Equity Financing Round for Animal-Free Beauty Ingredients, Bringing Total Amount Raised to $137M

Geltor, a biodesign company developing sustainable, animal-free proteins for the beauty and wellness industries, has closed a new equity financing round, bringing the total amount raised to $137 million. The round was co-led by iSelect Fund and included participation from existing investors. Geltor plans to make targeted investments in expanding its biodesigned polypeptide portfolio, bringing new solutions to market, and exploring AI-enabled polypeptide design and biomanufacturing.

The company has achieved key milestones, including launching vegan collagen polypeptides in Latin America and receiving FDA approval for its ingestible collagen product. Geltor's platform selects and optimizes amino acid sequences from databases of known protein sequences, replicating them through precision fermentation. The current product portfolio includes biomimetic collagen and elastin polypeptides for skincare, as well as vegan collagen for dietary supplements and beauty applications. CEO Alexander Lorestani sees the company as a go-to partner for biodesigned polypeptides at scale in the growing beauty and wellness markets.